Drugs / Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment
Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06396013 | Jun 2024 → Jun 2026 overdue | psoriasis | Beijing Hospital of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06396013 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “the Qinteng Huoxue prescription series of TCM topical preparations created by Professor Sun Liyun have been observed to be effective in clinical practice in the treatment of psoriasis” NCT06396013 ↗ |
| Route | Topical | “The experimental group received topical Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment, twice a day for 12 weeks” NCT06396013 ↗ |